MIST
Milestone Pharmaceuticals Inc.·Healthcare
2.02
0.498%(+0.01)
Market ClosedLast Updated: — ET
52W L: $0.7752W H: $3.06
MIST NEWS
globenewswire.com
22h ago
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascular Nursing Symposium Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascular Nursing Symposium
globenewswire.com
3d ago
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
MONTREAL and CHARLOTTE, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development of commercialization of innovative cardiovascular medicines, today announced that management will present at the 25 th Annual Needham Virtual Healthcare Conference to take place April 13 - 16, 2026.
globenewswire.com
Apr 2
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MONTREAL and CHARLOTTE, N.C., April 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a total of 123,000 options (the “Options”) to purchase the Company's common shares, pursuant to the Company's 2021 Inducement Plan (the “Plan”), previously approved by the Company's Compensation Committee and the Board of Directors, as a material inducement to the hiring of three new employees.
globenewswire.com
Mar 31
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies
MONTREAL and CHARLOTTE, N.C., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Express Scripts, one of the nation's largest pharmacy benefit managers, has added CARDAMYST™ (etripamil) nasal spray to its commercial national formularies, effective March 27, 2026.
seekingalpha.com
Mar 20
Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript
Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript
benzinga.com
Mar 20
Why Milestone Pharma Stock Is Taking A Dive Today
• Milestone Pharmaceuticals stock is taking a hit today. Why is MIST stock falling?
